Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Melanocytes | 3 | 2021 | 509 | 0.550 |
Why?
|
Melanoma | 7 | 2024 | 5709 | 0.550 |
Why?
|
Drug Eruptions | 1 | 2015 | 335 | 0.410 |
Why?
|
Microphthalmia-Associated Transcription Factor | 2 | 2024 | 257 | 0.360 |
Why?
|
Ultraviolet Rays | 3 | 2021 | 1104 | 0.280 |
Why?
|
Skin Pigmentation | 2 | 2021 | 281 | 0.250 |
Why?
|
Molecular Targeted Therapy | 2 | 2019 | 2830 | 0.230 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2021 | 69 | 0.190 |
Why?
|
SOXE Transcription Factors | 1 | 2021 | 73 | 0.190 |
Why?
|
Skin Diseases, Viral | 1 | 2021 | 26 | 0.190 |
Why?
|
Endorphins | 1 | 2021 | 73 | 0.190 |
Why?
|
Purpura | 1 | 2021 | 117 | 0.170 |
Why?
|
Interferon Regulatory Factors | 1 | 2021 | 271 | 0.170 |
Why?
|
Pressure Ulcer | 1 | 2021 | 159 | 0.170 |
Why?
|
Histocompatibility Antigens | 1 | 2020 | 479 | 0.160 |
Why?
|
Receptors, CXCR3 | 1 | 2019 | 240 | 0.150 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2024 | 958 | 0.150 |
Why?
|
Melanoma, Experimental | 2 | 2020 | 559 | 0.150 |
Why?
|
Neuroglia | 1 | 2023 | 960 | 0.140 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2017 | 50 | 0.140 |
Why?
|
Tumor Escape | 2 | 2017 | 372 | 0.140 |
Why?
|
Exanthema | 1 | 2021 | 503 | 0.130 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2021 | 778 | 0.130 |
Why?
|
Reactive Oxygen Species | 1 | 2024 | 2149 | 0.130 |
Why?
|
Skin Diseases, Papulosquamous | 1 | 2015 | 17 | 0.130 |
Why?
|
Protein Biosynthesis | 1 | 2023 | 2094 | 0.130 |
Why?
|
Hypopigmentation | 1 | 2015 | 43 | 0.130 |
Why?
|
Zebrafish | 2 | 2024 | 3037 | 0.120 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2020 | 701 | 0.120 |
Why?
|
Immunomodulation | 1 | 2019 | 549 | 0.120 |
Why?
|
Skin Neoplasms | 1 | 2014 | 5864 | 0.120 |
Why?
|
Antigens, Neoplasm | 2 | 2021 | 2001 | 0.120 |
Why?
|
Chromosome Mapping | 1 | 2023 | 4625 | 0.120 |
Why?
|
Reverse Transcription | 1 | 2014 | 48 | 0.120 |
Why?
|
Moloney murine leukemia virus | 1 | 2014 | 110 | 0.120 |
Why?
|
Nucleocapsid Proteins | 1 | 2014 | 75 | 0.120 |
Why?
|
Dermatology | 2 | 2022 | 905 | 0.120 |
Why?
|
Epitopes | 1 | 2021 | 2529 | 0.120 |
Why?
|
Oncogenes | 1 | 2020 | 1236 | 0.110 |
Why?
|
Neoplasms | 3 | 2019 | 22389 | 0.110 |
Why?
|
RNA, Messenger | 3 | 2023 | 12806 | 0.110 |
Why?
|
RNA | 1 | 2023 | 2727 | 0.110 |
Why?
|
Sunlight | 1 | 2014 | 337 | 0.100 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13698 | 0.100 |
Why?
|
Immunotherapy | 3 | 2021 | 4756 | 0.100 |
Why?
|
Forkhead Transcription Factors | 1 | 2020 | 1625 | 0.100 |
Why?
|
RNA, Transfer | 1 | 2014 | 284 | 0.100 |
Why?
|
Pruritus | 1 | 2015 | 379 | 0.100 |
Why?
|
Hair Color | 1 | 2012 | 131 | 0.100 |
Why?
|
Vitamin D Deficiency | 1 | 2021 | 1388 | 0.090 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2024 | 8664 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2020 | 2059 | 0.090 |
Why?
|
Skin Diseases | 1 | 2019 | 1085 | 0.090 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2014 | 542 | 0.090 |
Why?
|
Referral and Consultation | 2 | 2022 | 3628 | 0.090 |
Why?
|
Mice | 9 | 2023 | 82072 | 0.080 |
Why?
|
Monophenol Monooxygenase | 2 | 2021 | 72 | 0.070 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4862 | 0.070 |
Why?
|
Drug Approval | 1 | 2014 | 821 | 0.070 |
Why?
|
Length of Stay | 1 | 2021 | 6526 | 0.070 |
Why?
|
Animals | 12 | 2024 | 169335 | 0.070 |
Why?
|
Opioid-Related Disorders | 1 | 2021 | 2188 | 0.070 |
Why?
|
RNA, Viral | 1 | 2014 | 2871 | 0.060 |
Why?
|
Epigenesis, Genetic | 2 | 2019 | 3836 | 0.060 |
Why?
|
Cell Line, Tumor | 5 | 2024 | 17173 | 0.060 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2019 | 3621 | 0.060 |
Why?
|
Models, Molecular | 1 | 2014 | 5404 | 0.060 |
Why?
|
Telemedicine | 1 | 2022 | 3110 | 0.060 |
Why?
|
Neurons | 1 | 2023 | 9519 | 0.060 |
Why?
|
DNA Damage | 2 | 2024 | 2472 | 0.050 |
Why?
|
Mice, Inbred C57BL | 5 | 2021 | 22379 | 0.050 |
Why?
|
Humans | 19 | 2024 | 768970 | 0.050 |
Why?
|
Melanosomes | 1 | 2021 | 34 | 0.050 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 1105 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2021 | 6131 | 0.040 |
Why?
|
Prone Position | 1 | 2021 | 203 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8055 | 0.040 |
Why?
|
Hospitals, Urban | 1 | 2021 | 499 | 0.040 |
Why?
|
Disease Progression | 1 | 2015 | 13674 | 0.040 |
Why?
|
Gene Expression Regulation | 3 | 2023 | 11932 | 0.040 |
Why?
|
Zebrafish Proteins | 1 | 2024 | 1019 | 0.040 |
Why?
|
Cyclic AMP | 1 | 2021 | 1469 | 0.030 |
Why?
|
HeLa Cells | 1 | 2023 | 3076 | 0.030 |
Why?
|
Ubiquitin | 1 | 2021 | 843 | 0.030 |
Why?
|
Brain | 1 | 2023 | 27453 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1839 | 0.030 |
Why?
|
Kinetics | 1 | 2023 | 6332 | 0.030 |
Why?
|
Unfolded Protein Response | 1 | 2017 | 239 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2021 | 2226 | 0.030 |
Why?
|
Indoles | 2 | 2014 | 1836 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2021 | 1320 | 0.030 |
Why?
|
Mutation | 2 | 2020 | 30266 | 0.030 |
Why?
|
Cell Line | 2 | 2021 | 15604 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2021 | 81903 | 0.030 |
Why?
|
Immunocompetence | 1 | 2014 | 138 | 0.030 |
Why?
|
Survival Analysis | 2 | 2020 | 10115 | 0.030 |
Why?
|
Sulfonamides | 2 | 2014 | 1981 | 0.030 |
Why?
|
Interferons | 1 | 2017 | 720 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 11886 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2019 | 4651 | 0.030 |
Why?
|
Intubation, Intratracheal | 1 | 2021 | 1359 | 0.030 |
Why?
|
Vitamins | 1 | 2021 | 1638 | 0.030 |
Why?
|
Receptor, Melanocortin, Type 1 | 1 | 2012 | 74 | 0.030 |
Why?
|
Peroxidases | 1 | 2012 | 135 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2021 | 10486 | 0.020 |
Why?
|
Lymphocyte Count | 1 | 2014 | 794 | 0.020 |
Why?
|
Antigen Presentation | 1 | 2017 | 1252 | 0.020 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2014 | 508 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6320 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2023 | 2542 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1813 | 0.020 |
Why?
|
T-Lymphocytes | 2 | 2020 | 10276 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2021 | 3726 | 0.020 |
Why?
|
Genome, Viral | 1 | 2014 | 673 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2024 | 7609 | 0.020 |
Why?
|
Melanins | 1 | 2012 | 292 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2021 | 2784 | 0.020 |
Why?
|
Hospitalization | 2 | 2021 | 10847 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2015 | 65480 | 0.020 |
Why?
|
NF-kappa B | 1 | 2017 | 2492 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3904 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2019 | 5505 | 0.020 |
Why?
|
Mitochondria | 1 | 2021 | 3682 | 0.020 |
Why?
|
Medical Oncology | 1 | 2019 | 2350 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2014 | 3775 | 0.020 |
Why?
|
Vitamin D | 1 | 2021 | 3311 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12873 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2023 | 9549 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3952 | 0.020 |
Why?
|
Apoptosis | 1 | 2021 | 9527 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3838 | 0.010 |
Why?
|
Middle Aged | 4 | 2021 | 223737 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2019 | 14484 | 0.010 |
Why?
|
Aged | 3 | 2021 | 171786 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21547 | 0.010 |
Why?
|
Protein Binding | 1 | 2014 | 9344 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7460 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10765 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8749 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 16053 | 0.010 |
Why?
|
Genomics | 1 | 2017 | 5928 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 30046 | 0.010 |
Why?
|
Male | 4 | 2021 | 365203 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2014 | 3116 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18354 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 18068 | 0.010 |
Why?
|
Cytokines | 1 | 2014 | 7453 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41808 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9264 | 0.010 |
Why?
|
Female | 3 | 2021 | 397515 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2012 | 5707 | 0.010 |
Why?
|
Adult | 2 | 2021 | 223851 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 59739 | 0.010 |
Why?
|
Concepts
(153)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(51)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_